![Hans-Jürgen Tiedtke](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hans-Jürgen Tiedtke
Chief Tech/Sci/R&D Officer at IMI Intelligent Medical Implants AG
Hans-Jürgen Tiedtke active positions
Companies | Position | Start | End |
---|---|---|---|
IMI Intelligent Medical Implants AG
![]() IMI Intelligent Medical Implants AG Medical DistributorsDistribution Services IMI Intelligent Medical Implants is a medical technology company. The goal of the company is to develop and market an intelligent retinal implant system for degenerative retinal disorders such as Retinitis Pigmentosa or Macular Degeneration and thereby make a contribution to the improvement of the quality of life of blind people. Through the combination of innovative technology from the medical device, IT and micro systems fields, a new class of active medical products has been created allowing, amongst other things, blind people to regain modest visual perception. The company was founded in 2002 and has 30 employees. The company has a process oriented quality management system in accordance with ISO 13485. | Chief Tech/Sci/R&D Officer | - | - |
President | - | 28/07/2009 |
Career history of Hans-Jürgen Tiedtke
Former positions of Hans-Jürgen Tiedtke
Companies | Position | Start | End |
---|---|---|---|
HP-medica GmbH | President | - | 31/12/2002 |
Training of Hans-Jürgen Tiedtke
RWTH Aachen University | Undergraduate Degree |
Statistics
International
Germany | 3 |
Switzerland | 2 |
Operational
President | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Sectoral
Distribution Services | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
IMI Intelligent Medical Implants AG
![]() IMI Intelligent Medical Implants AG Medical DistributorsDistribution Services IMI Intelligent Medical Implants is a medical technology company. The goal of the company is to develop and market an intelligent retinal implant system for degenerative retinal disorders such as Retinitis Pigmentosa or Macular Degeneration and thereby make a contribution to the improvement of the quality of life of blind people. Through the combination of innovative technology from the medical device, IT and micro systems fields, a new class of active medical products has been created allowing, amongst other things, blind people to regain modest visual perception. The company was founded in 2002 and has 30 employees. The company has a process oriented quality management system in accordance with ISO 13485. | Distribution Services |
HP-medica GmbH |
- Stock Market
- Insiders
- Hans-Jürgen Tiedtke
- Experience